b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30375272</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>01</Month>\n            <Day>02</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>01</Month>\n            <Day>02</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">2046-9055</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>39</Volume>\n                    <Issue>2</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>05</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Paediatrics and international child health</Title>\n                <ISOAbbreviation>Paediatr Int Child Health</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>In neonates with vitamin D deficiency, low lymphocyte activation markers are risk factors for infection.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>111-118</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1080/20469047.2018.1528755</ELocationID>\n            <Abstract>\n                <AbstractText><b>Background</b>: Vitamin D has regulatory effects on different cells of the immune system and low levels are associated with several immune-mediated diseases. <b>Aim</b>: To investigate the association between neonatal 25-hydroxy vitamin D (25-OHD) level and the expression of lymphocyte activation markers (HLA-DR, CD69, CD25, CD45RA) on T-lymphocyte subpopulations and its impact in neonatal infection. <b>Methods</b>: 25-OHD level was measured in the cord blood of 56 neonates and their mothers using an enzyme immune-assay method. Based on the 25-OHD level, infants were categorised into four groups: severe deficiency (<i>n\xc2\xa0=\xc2\xa0</i>7), moderate deficiency (<i>n\xc2\xa0=\xc2\xa0</i>21), mild deficiency (<i>n\xc2\xa0=\xc2\xa0</i>15) and normal 25-OHD level (<i>n\xc2\xa0=\xc2\xa0</i>13). Mothers were classified into deficient (<i>n\xc2\xa0=\xc2\xa0</i>18), insufficient (<i>n\xc2\xa0=\xc2\xa0</i>21) and normal levels (<i>n\xc2\xa0=\xc2\xa0</i>17). T-lymphocyte subpopulations and lymphocyte activation markers were investigated using flow cytometry. <b>Results</b>: There was a positive correlation between maternal and cord blood 25-OHD levels (<i>r\xc2\xa0</i>=\xc2\xa00.503, <i>p\xc2\xa0</i>=\xc2\xa00.001). The group with severe 25-OHD deficiency had the significantly lowest level of total lymphocytes, CD3+ T lymphocytes, CD4+ T-helper and CD8+ T-cytotoxic lymphocytes and CD4+CD45RA+ na\xc3\xafve T-cells compared with the other groups. The frequencies of CD8+CD25+, CD4+CD25+ and CD4+HLA-DR+ activated T-lymphocytes were significantly lower in the severe, moderate and mild deficiency groups than in the normal group. Seven of 43 (16.27%) infants with 25-OHD deficiency were admitted with sepsis to the neonatal intensive care unit and there were no cases of sepsis in the normal 25-OHD group. <b>Conclusion</b>: Vitamin D deficiency is associated with a reduction of lymphocyte subsets and altered T-lymphocyte activation which are considered to be risk factors for neonatal infection.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Youssef</LastName>\n                    <ForeName>Mervat A M</ForeName>\n                    <Initials>MAM</Initials>\n                    <Identifier Source="ORCID">0000-0002-9054-0662</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>a Children Hospital, Faculty of Medicine , Assiut University , Egypt.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zahran</LastName>\n                    <ForeName>Asmaa M</ForeName>\n                    <Initials>AM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>b Clinical Pathology Department, South Egypt Cancer Institute , Assiut University , Assiut , Egypt.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hussien</LastName>\n                    <ForeName>Al Montasser</ForeName>\n                    <Initials>AM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>a Children Hospital, Faculty of Medicine , Assiut University , Egypt.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Elsayh</LastName>\n                    <ForeName>Khalid I</ForeName>\n                    <Initials>KI</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>a Children Hospital, Faculty of Medicine , Assiut University , Egypt.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Askar</LastName>\n                    <ForeName>Eman A</ForeName>\n                    <Initials>EA</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>a Children Hospital, Faculty of Medicine , Assiut University , Egypt.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Farghaly</LastName>\n                    <ForeName>Hekma Saad</ForeName>\n                    <Initials>HS</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>a Children Hospital, Faculty of Medicine , Assiut University , Egypt.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>30</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>Paediatr Int Child Health</MedlineTA>\n            <NlmUniqueID>101582666</NlmUniqueID>\n            <ISSNLinking>2046-9047</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D015703">Antigens, CD</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000945">Antigens, Differentiation, T-Lymphocyte</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C055855">CD69 antigen</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D006684">HLA-DR Antigens</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C508017">IL2RA protein, human</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D053645">Interleukin-2 Receptor alpha Subunit</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D037181">Lectins, C-Type</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 3.1.3.48</RegistryNumber>\n                <NameOfSubstance UI="D017493">Leukocyte Common Antigens</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015703" MajorTopicYN="N">Antigens, CD</DescriptorName>\n                <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000945" MajorTopicYN="N">Antigens, Differentiation, T-Lymphocyte</DescriptorName>\n                <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003141" MajorTopicYN="N">Communicable Diseases</DescriptorName>\n                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004198" MajorTopicYN="Y">Disease Susceptibility</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006684" MajorTopicYN="N">HLA-DR Antigens</DescriptorName>\n                <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D053645" MajorTopicYN="N">Interleukin-2 Receptor alpha Subunit</DescriptorName>\n                <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D037181" MajorTopicYN="N">Lectins, C-Type</DescriptorName>\n                <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D017493" MajorTopicYN="N">Leukocyte Common Antigens</DescriptorName>\n                <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008213" MajorTopicYN="Y">Lymphocyte Activation</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016176" MajorTopicYN="N">T-Lymphocyte Subsets</DescriptorName>\n                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>\n                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014808" MajorTopicYN="N">Vitamin D Deficiency</DescriptorName>\n                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">CD25</Keyword>\n            <Keyword MajorTopicYN="Y">CD45RA</Keyword>\n            <Keyword MajorTopicYN="Y">HLA-DR</Keyword>\n            <Keyword MajorTopicYN="Y">neonate</Keyword>\n            <Keyword MajorTopicYN="Y">sepsis</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>31</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>3</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>31</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30375272</ArticleId>\n            <ArticleId IdType="doi">10.1080/20469047.2018.1528755</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'